Unknown

Dataset Information

Extended-Release Injectable Naltrexone (XR-NTX) With Intensive Psychosocial Therapy for Amphetamine-Dependent Persons Seeking Treatment: A Placebo-Controlled Trial.


ABSTRACT:

Objective

Explore the efficacy of extended-release injectable naltrexone (XR-NTX) for preventing relapse to amphetamine use.

Method

Clinical trial of 100 amphetamine-dependent, treatment-seeking patients who were randomized to 6 monthly 380 mg doses of XR-NTX or matching placebo before entering intensive outpatient after varying lengths of inpatient treatment in Reykjavik, Iceland. Weekly urine drug tests, retention, and standardized instruments assessed efficacy.

Results

Of 169 approached, 100 were randomized. Although amphetamine dependence was the main reason for seeking treatment, three-quarters or more of participants had 1 or more other substance dependencies. Of 51 randomized to XR-NTX, 20 received 4 or more injections; of 49 assigned to placebo, 26 received 4

SUBMITTER: Runarsdottir V 

PROVIDER: S-EPMC5449233 | biostudies-literature | 2017 May/Jun

REPOSITORIES: biostudies-literature